{"ok":true,"entity":{"id":"abbott-laboratories","name":"Abbott Laboratories","entityType":"company","officialName":"Abbott Laboratories","canonicalName":"Abbott Laboratories","displayName":"Abbott Laboratories","category":"総合ヘルスケア企業（診断・医療機器・栄養・医薬品）","shortDescription":"イリノイ州アボットパークに本社を置くNYSE上場（ABT）の総合ヘルスケア企業で、診断、医療機器、栄養、医薬品（Established Pharmaceuticals）などを手がける。2026年3月23日にExact Sciencesの買収を完了し、同社を完全子会社とした。2026年第2四半期の売上高は125.93億ドル（前年同期比+13.0%）で、2026年通期の調整後EPSガイダンスを5.45〜5.60ドルへ引き上げた。","primaryCluster":"medical-device","parentEntity":null,"verificationStatus":"draft","website":"https://www.abbott.com/","updatedAt":"2026-10-13T05:36:43.320Z","secondaryClusters":[],"alias":["Abbott","アボット","アボット・ラボラトリーズ"],"searchKeywords":["Abbott","Abbott Laboratories","アボット","アボット・ラボラトリーズ","ABT","FreeStyle Libre","診断","医療機器","Exact Sciences 買収","総合ヘルスケア"]},"referenceIndex":["P-01-001","P-02-001","P-04-001","P-05-001","P-06-001"]}